M - Emergent Biosolutions Non-GAAP EPS of -$1.06 misses by $0.43 revenue of $337.9M beats by $121.15M
2023-08-08 16:37:49 ET
- Emergent Biosolutions press release ( NYSE: EBS ): Q2 Non-GAAP EPS of -$1.06 misses by $0.43 .
- Revenue of $337.9M (+39.2% Y/Y) beats by $121.15M .
- Guidance FY: Total Revenues $1,000M - $1,100M vs $1.16B consensus; Adj. net loss $(195M) - $(145M)
For further details see:
Emergent Biosolutions Non-GAAP EPS of -$1.06 misses by $0.43, revenue of $337.9M beats by $121.15M